Are We Nearing an Era of Chemotherapy-Free Management of Indolent Lymphoma?

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-0437
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Are We Approaching the End of the LNT Model Era?

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Hodgkin Lymphoma Classification: Are We at a Crossroads?

Cancer
Cancer ResearchOncology
2017English

Characteristics and Management of Rash Following Lenalidomide and Rituximab in Patients With Untreated Indolent Non-Hodgkin Lymphoma

Haematologica
Hematology
2015English

Use of Fludarabine for the Treatment of Indolent Lymphoma With Chylothorax

Klinicka Onkologie
Oncology
2018English

Antimicrobial Resistance: Are We at the Dawn of the Post-Antibiotic Era?

Journal of the Royal College of Physicians of Edinburgh, The
MedicineEducationHistory
2016English

Medical Uncertainty: Are We Better Off in Era of Evidence Based Medicine?

International Journal of Medical Research & Health Sciences
2015English

Are We Sure About the Benefits of Opioid Free Anesthesia?

Translational Perioperative and Pain Medicine
2020English

Novel Chemotherapy-Free Combination Regimen for Ibrutinib-Resistant Mantle Cell Lymphoma

British Journal of Haematology
Hematology
2017English

Multidisciplinary Management of Hepatocellular Carcinoma: Where Are We Today?

Seminars in Liver Disease
Hepatology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy